Atlas Trials

Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma

Clinical trial NCT01005745 · COMPLETED

Trial details

NCT number
NCT01005745
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Melanoma
Start date
2009-10-20
Primary completion
2014-01-31
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.